| A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice Y Hao, P O'Neill, MS Naradikian, JL Scholz, MP Cancro Blood, The Journal of the American Society of Hematology 118 (5), 1294-1304, 2011 | 510 | 2011 |
| Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses N Pardi, MJ Hogan, MS Naradikian, K Parkhouse, DW Cain, L Jones, ... Journal of Experimental Medicine 215 (6), 1571-1588, 2018 | 443 | 2018 |
| Cutting edge: IL-4, IL-21, and IFN-γ interact to govern T-bet and CD11c expression in TLR-activated B cells MS Naradikian, A Myles, DP Beiting, KJ Roberts, L Dawson, RS Herati, ... The Journal of Immunology 197 (4), 1023-1028, 2016 | 202 | 2016 |
| The transcription factor T-bet resolves memory B cell subsets with distinct tissue distributions and antibody specificities in mice and humans JL Johnson, RL Rosenthal, JJ Knox, A Myles, MS Naradikian, J Madej, ... Immunity 52 (5), 842-855. e6, 2020 | 168 | 2020 |
| Age‐associated B cells: key mediators of both protective and autoreactive humoral responses MS Naradikian, Y Hao, MP Cancro Immunological reviews 269 (1), 118-129, 2016 | 133 | 2016 |
| Age-associated B cells express a diverse repertoire of VH and Vκ genes with somatic hypermutation LM Russell Knode, MS Naradikian, A Myles, JL Scholz, Y Hao, D Liu, ... The Journal of Immunology 198 (5), 1921-1927, 2017 | 116 | 2017 |
| A TLR9-dependent checkpoint governs B cell responses to DNA-containing antigens VJ Sindhava, MA Oropallo, K Moody, M Naradikian, LE Higdon, L Zhou, ... The Journal of clinical investigation 127 (5), 1651-1663, 2017 | 80 | 2017 |
| Harnessing neoantigen specific CD4 T cells for cancer immunotherapy SE Brightman, MS Naradikian, AM Miller, SP Schoenberger Journal of leukocyte biology 107 (4), 625-633, 2020 | 46 | 2020 |
| BAFF receptors and ligands create independent homeostatic niches for B cell subsets MS Naradikian, AR Perate, MP Cancro Current opinion in immunology 34, 126-129, 2015 | 46 | 2015 |
| Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells T Tokatlian, GE Asuelime, JY Mock, B DiAndreth, S Sharma, ... Journal for Immunotherapy of Cancer 10 (1), 2022 | 34 | 2022 |
| Transcription factor zinc finger and BTB domain 1 is essential for lymphocyte development D Punwani, K Simon, Y Choi, A Dutra, D Gonzalez-Espinosa, E Pak, ... The Journal of Immunology 189 (3), 1253-1264, 2012 | 31 | 2012 |
| B Cell–Intrinsic Expression of the HuR RNA-Binding Protein Is Required for the T Cell–Dependent Immune Response In Vivo A DeMicco, MS Naradikian, VJ Sindhava, JH Yoon, M Gorospe, ... The Journal of Immunology 195 (7), 3449-3462, 2015 | 29 | 2015 |
| Memory B cells form in aged mice despite impaired affinity maturation and germinal center kinetics R Goenka, JL Scholz, MS Naradikian, MP Cancro Experimental gerontology 54, 109-115, 2014 | 26 | 2014 |
| Understanding B cell biology MS Naradikian, JL Scholz, MA Oropallo, MP Cancro Drugs Targeting B-Cells in Autoimmune Diseases, 11-35, 2014 | 21 | 2014 |
| Neoantigen-specific stem cell memory-like CD4+ T cells mediate CD8+ T cell-dependent immunotherapy of MHC class II-negative solid tumors SE Brightman, A Becker, RR Thota, MS Naradikian, L Chihab, KS Zavala, ... Nature immunology 24 (8), 1345-1357, 2023 | 15 | 2023 |
| Tumor cells fail to present MHC-II–restricted epitopes derived from oncogenes to CD4+ T cells SE Brightman, MS Naradikian, RR Thota, A Becker, L Montero, ... JCI insight 8 (2), 2023 | 8 | 2023 |
| Chimeric antigen receptors directed at mutant KRAS exhibit an inverse relationship between functional potency and neoantigen selectivity T Tokatlian, GE Asuelime, MS Naradikian, JY Mock, ME Daris, AD Martin, ... Cancer Research Communications 2 (1), 58-65, 2022 | 3 | 2022 |
| HLA-A∗ 02-gated safety switch for cancer therapy has exquisite specificity for its allelic target antigen JY Mock, A Winters, TP Riley, R Bruno, MS Naradikian, S Sharma, ... Molecular Therapy-Oncolytics 27, 157-166, 2022 | 1 | 2022 |
| 263 A2B694, an autologous logic-gated cell therapy targeting mesothelin J Molina, T Tokatlian, J Wang, S Sharma, D Manry, M Naradikian, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 1 | 2022 |
| A functional identification platform reveals frequent, spontaneous neoantigen-specific T cell responses in patients with cancer AM Miller, Z Koşaloğlu-Yalçın, L Westernberg, L Montero, M Bahmanof, ... Science Translational Medicine 16 (736), eabj9905, 2024 | | 2024 |
Michael P CancroProfessor of Pathology and Laboratory Medicine, University of PennsylvaniaVerified email at pennmedicine.upenn.edu
